Sp1276
PARTNERING WITH PATIENTS FOR THE MANAGEMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS USING AN ORAL PRESCRIPTION THERAPY
Date
May 7, 2023
Society: DDW
Dr. Bincy Abraham and Gabriella McCarty, NP, will discuss proactive patient involvement in shared decision-making by incorporating a case-based approach within the clinical overview of an oral prescription therapy for moderate-to-severe ulcerative colitis. Sponsored by Pfizer
Dr. Bincy Abraham and Gabriella McCarty, NP, will discuss proactive patient involvement in shared decision-making by incorporating a case-based approach within the clinical overview of an oral prescription therapy for moderate-to-severe ulcerative colitis. Sponsored by Pfizer
Presenter
Houston Methodist
Speaker
Tracks
Related Products
Emerging Strategies for the Management of Complicated IBD
This session will examine a variety of alternate strategies for the management of complicated IBD including stem cell transplantation and novel therapies…
PERSISTENCE OF SPLANCHNIC GENE SIGNATURE DEFINES A TUMOR-RESTRAINING FIBROBLAST SUBTYPE IN PANCREATIC CANCER
The pancreas is composed of the epithelial and mesenchymal cells. Interaction between the two lineages guides proper formation of the pancreas and modulates progression of pancreatic diseases such as cancer…
GI DISEASES IN PREGNANCY
The AGA Board Review Course held annually at DDW provides attendees with the information they need to stay current in their practice and prepare for both the ABIM recertification and initial certification exams in gastroenterology…
